IADR Abstract Archives

Connective Tissue Graft and Enamel Matrix Derivative for Periodontal Recession

Objectives: To compare the effectiveness and stability of subepithelial connective tissue graft (SCTG) with and without enamel matrix derivative (EMD) in the treatment of Class I-II Miller periodontal recession defects.
Methods: This randomized clinical study was performed over 2 years. 120 teeth divided into two groups: Group 1 (SCTG with EMD - 68 teeth) and Group 2 (SCTG only - 52 teeth) were assessed. Clinical parameters such as Recession values (REC), Keratinized Tissue (KT), Attachment Loss (AL) and Probing Depth (PD) were measured at baseline, 3 and 24 months.
Results: Both treatments showed significant root coverage after 2 years. The mean periodontal recession decreased from 4.5 mm to 0.41 mm for Group 1 (91%) and 4.2 mm to 0.29 mm in Group 2 (93%). No statistically significant difference between the treatment options was observed. The mean attachment loss reduced from 5.95 mm to 1.55 mm for Group 1 and 5.55 mm to 1.35 mm in Group 2. This was not statistically significant. The mean KT increased from 1.5 mm to 2.5 mm in Group 1 and 1.6 mm to 1.9 mm in Group 2. This increase was statistically significantly (p< 0.01) higher in the EMD treated group.
Conclusions: SCTG provides predictable results in achieving root coverage in Class I-II Miller periodontal recessions. The addition of EMD seems to provide significantly higher amounts of new keratinized tissue.
IADR/AADR/CADR General Session
2017 IADR/AADR/CADR General Session (San Francisco, California)
San Francisco, California
2017
1181
Periodontal Research-Therapy
  • Mercado, Faustino  ( Griffith University , Sydney , Queensland , Australia ;  Specialist Dental Centre , Sydney , New South Wales , Australia )
  • National Health and Medical Research Council - Australia
    NONE
    Oral Session
    New Advances in Periodontal Plastic Surgery
    Thursday, 03/23/2017 , 02:00PM - 03:30PM
    Table 1. Recession measurements (mm) at baseline, 3rd month and 24 months after SCTG with EMD (Group 1) and without EMD (Group 2)
    PeriodGroupsMean (mm)SD
    BaselineGrp 14.57-+ 1.55
     Grp. 24.26-+1.33
    3rd MonthGrp.1.24-+.18
     Grp.2.11-+.05
    24th MonthGrp.1.41-+.52
     Grp.2.29-+.46
        
    REC improvement is not statistically significant from baseline to 24th month between groups 1 and 2
    Table 2. Keratinised Tissue (mm) at baseline, 3rd month and 24 months after SCTG with EMD (Group 1) and without EMD (Group 2)
    PeriodGroupsMean (mm)SD
    BaselineGrp. 11.5-+.46
     Grp.21.6-+.49
    3rd MonthGrp.12.2-+.53
     Grp.21.8-+.32
    24th MonthGrp.12.4-+.55
     Grp.21.8-+.39
    KT is statistically significant from Baseline to 24th month between groups 1 and 2 (p<.01)